Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers

MT Newswires Live

2024-10-28

Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.

Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.

Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.

Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.

Price: 3.8500, Change: -0.39, Percent Change: -9.20

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2478102976"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478102976\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2478102976?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478102976","market":"sh","top_or_hot":-1,"title":"Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers","media":"MT Newswires Live","content":"<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-28 20:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1093756325.SGD","symbol_name":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478102976","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478102976","pubTimestamp":1730118040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Fennec Pharmaceuticals  said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics , Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4139":"生物科技","HZNP":"Horizon Pharma","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","FENC":"Fennec Pharmaceuticals Inc.","BK4532":"文艺复兴科技持仓","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC"},"translate_title":"Fennec Pharmaceuticals任命首席医疗、商业和战略官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FENC":0.9,"HZNP":0.9},"content_text":"Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}